Pemetrexed Disodium in Treating Patients With Persistent or Recurrent Endometrial Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- David S. Miller, MD
Simmons Cancer Center
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
23 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Jonsson Comprehensive Cancer Center at Ucla
Los Angeles, California, United States
- Hinsdale Hematology Oncology Associates
Hinsdale, Illinois, United States
- Ccop - Carle Cancer Center
Urbana, Illinois, United States
- St. Vincent Indianapolis Hospital
Indianapolis, Indiana, United States
- Holden Comprehensive Cancer Center at University of Iowa
Iowa City, Iowa, United States
- Massachusetts General Hospital
Boston, Massachusetts, United States
- West Michigan Cancer Center
Kalamazoo, Michigan, United States
- University of Mississippi Cancer Clinic
Jackson, Mississippi, United States
- Hulston Cancer Center at Cox Medical Center South
Springfield, Missouri, United States
- St. John'S Regional Health Center
Springfield, Missouri, United States
- Suny Downstate Medical Center
Brooklyn, New York, United States
- Alamance Cancer Center at Alamance Regional Medical Center
Burlington, North Carolina, United States
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill
Chapel Hill, North Carolina, United States
- Case Comprehensive Cancer Center
Cleveland, Ohio, United States
- Cleveland Clinic Taussig Cancer Center
Cleveland, Ohio, United States
- Riverside Methodist Hospital Cancer Care
Columbus, Ohio, United States
- David L. Rike Cancer Center at Miami Valley Hospital
Dayton, Ohio, United States
- Lake/university Ireland Cancer Center
Mentor, Ohio, United States
- Oklahoma University Cancer Institute
Oklahoma City, Oklahoma, United States
- Cancer Care Associates - Midtown Tulsa
Tulsa, Oklahoma, United States
- Rosenfeld Cancer Center at Abington Memorial Hospital
Abington, Pennsylvania, United States
- Avera Cancer Institute
Sioux Falls, South Dakota, United States
- Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas
Dallas, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 May 2006
- Primary completion
- 31 Aug 2007
- Completion
- —
- Last update posted
- 14 Feb 2014
- Registered enrollment
- 51
- Registry id
- NCT00087100
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.